Ironwood Pharmaceuticals | IRWD - Себестоимость





Себестоимость Изменить Дата
Acadia Pharmaceuticals USD 28.32M 3.52M 2026-06
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Akebia Therapeutics USD 10.34M 441K 2025-12
Almirall EUR 199.26M 7.76M 2026-06
Alnylam Pharmaceuticals USD 298.45M 87.33M 2026-06
Amarin USD 26.05M 1.41M 2025-12
Ardelyx USD 4.81M 6.04M 2026-03
Astellas Pharma JPY 158.38B 28.94B 2026-06
AstraZeneca USD 2.52B 2.73B 2026-06
Charles River Laboratories USD 655.29M 61.22M 2026-06
Coherus Biosciences USD 4.04M 324K 2025-12
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Halozyme Therapeutics USD 108.68M 67K 2026-06
Incyte USD 104.96M 457K 2026-06
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Karyopharm Therapeutics USD 1.34M 139K 2026-03
Lexicon Pharmaceuticals USD 201K 191K 2025-12
MacroGenics USD 9.53M 585K 2026-03
Moderna USD 93M 862M 2026-06
Myriad Genetics USD 63M 1.1M 2025-12
Pacira USD 58.49M 7.75M 2026-06
PTC Therapeutics USD 39.61M 23.31M 2026-03
Puma Biotechnology USD 29.1M 18.44M 2024-09
Sarepta Therapeutics USD 150.1M 40.64M 2026-06
Takeda JPY 517.6B 42.94B 2026-06
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12